Validation of the Omron M3 Intellisense (HEM-7051-E) Upper Arm Blood Pressure Monitor, for Self-Measurement, according to the European Society of Hypertension International Protocol Revision 2010 in a Stage 3–5 Chronic Kidney Disease Population

Publisher： Karger

E-ISSN： 1423-0143|35|2|82-88

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.35, Iss.2, 2011-09, pp. : 82-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?

By  

Nephron, Vol. 135, Iss. 4, 2017-02 ,pp. : 287-290

Karger

Access to resources Recommend Favorite

Blood Pressure Variability in Chronic Kidney Disease Patients

By  

Blood Purification, Vol. 36, Iss. 1, 2013-05 ,pp. : 58-62

Karger

Access to resources Recommend Favorite

Practical Use of Home Blood Pressure Monitoring in Chronic Kidney Disease

By  

Cardiorenal Medicine, Vol. 4, Iss. 2, 2014-06 ,pp. : 113-122

Karger

Access to resources Recommend Favorite

Effects of Carvedilol as Third-Line Add-On Therapy on Blood Pressure and Glucose Metabolism in Type 2 Diabetic Patients with Chronic Renal Disease Stage 3 and Above

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-10 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Echocardiographic Changes in Patients with Stage 3-5 Chronic Kidney Disease and Left Ventricular Diastolic Dysfunction

By  

Cardiorenal Medicine, Vol. 4, Iss. 3-4, 2014-11 ,pp. : 234-243

Karger

Access to resources Recommend Favorite